By contrast, the expression levels of mesenchymal markers including fibronectin, vimentin and α-SMA were strongly up-regulated in BLM-induced mice and almost down-regulated to the normal levels in iPS cell-treated mice (Figure 7C). This evidence concerns the gene ACTA1 and Bloom syndrome.